logo
Join/ Subscribe

Subscribe

We recognize the significance of content in the modern digital world. Sign up on our website to receive the most recent technology trends directly in your email inbox..


Safe and Secure

Free Articles

logo
Join/ Subscribe Us

Subscribe

We recognize the significance of content in the modern digital world. Sign up on our website to receive the most recent technology trends directly in your email inbox.





    We assure a spam-free experience. You can update your email preference or unsubscribe at any time and we'll never share your information without your consent. Click here for Privacy Policy.


    Safe and Secure

    Free Articles

    News-posts

    KnowledgeNile is the one of the emerging technology content marketing organizations. 

    Vizit and Salsify Partner to Deliver AI-Powered Conversion Optimizer Application, Elevating Ecommerce Sales to New Heights
    Vizit and Salsify Partner to Deliver AI-Powered Conversion Optimizer Application, Elevating Ecommerce Sales to New Heights
    Vizit’s Conversion Optimizer, now integrated with the Salsify PXM Advance platform, drives a 10% surge in ecommerce sales for brands BOSTON, March 27, 2024 -- Vizit, the leading AI-powered visual content effectiveness platform for brands, retailers, and creators, and Salsify, the leading Product Experience Management (PXM) platform enabling brand manufacturers, distributors, and retailers to excel […]
    Ambiq Apollo510 Delivers 30x Power Efficiency Improvement to Unleash Endpoint AI
    Ambiq Apollo510 Delivers 30x Power Efficiency Improvement to Unleash Endpoint AI
    The next-generation Apollo pairs vector acceleration with unmatched power efficiency to enable most AI inferencing on-device without a dedicated NPU Feature Highlights Apollo510, based on Arm Cortex-M55, delivers 30x better power efficiency and 10x faster performance compared to previous generations The ability to do AI/ML workloads concurrent with complex graphics, telco-quality voice applications, and always-on […]
    Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates
    Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, and ABL Bio Inc. (“ABL”, KOSDAQ: 298380), a Korean clinical-stage biotechnology company developing novel therapeutics in oncology and CNS diseases, today announced a collaboration to develop new bispecific antibody-drug conjugates […]
    Scroll to Top